CC
The Chemours Company NYSE Listed Jun 19, 2015$21.77
After hrs
$21.99
+1.01%
Mkt Cap $3.3B
52w Low $10.14
62.8% of range
52w High $28.67
50d MA $23.30
200d MA $17.39
P/E (TTM)
-8.6x
EV/EBITDA
20.8x
P/B
13.0x
Debt/Equity
18.3x
ROE
-18.8%
P/FCF
64.3x
RSI (14)
46.00
ATR (14)
$1.09
Beta
1.40
50d MA
$23.30
200d MA
$17.39
Avg Volume
2.7M
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and others applications. The Chemical Solutions segment comprises a portfolio of industrial chemicals used as raw materials and catalysts for gold production, clean and disinfect, oil and gas, water treatment, electronics, and automotive applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.
1007 Market Street · Wilmington, DE 19899 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | -0.05 | -0.19 | -280.0% | 27.94 | -9.8% | -15.3% | -5.3% | +2.8% | +9.6% | -2.3% | — |
| Feb 19, 2026 | AMC | 0.09 | 0.05 | -43.6% | 20.41 | -8.7% | -16.5% | +5.8% | +2.1% | -2.1% | -3.9% | — |
| Nov 6, 2025 | AMC | 0.24 | 0.20 | -16.7% | 11.74 | -3.1% | +6.6% | +1.9% | -0.8% | -0.3% | -2.7% | — |
| Aug 5, 2025 | AMC | 0.46 | 0.58 | +26.1% | 12.63 | +4.7% | -5.0% | +1.5% | +0.1% | -4.2% | +6.3% | — |
| May 6, 2025 | AMC | 0.19 | 0.13 | -31.6% | 12.10 | -14.7% | -9.9% | +3.1% | -1.6% | +8.4% | -1.8% | — |
| Feb 18, 2025 | AMC | 0.10 | 0.11 | +10.0% | 17.48 | -4.3% | -1.8% | +1.9% | -4.1% | -3.6% | -2.2% | — |
| Nov 4, 2024 | AMC | 0.32 | 0.40 | +25.0% | 20.58 | -2.1% | -3.4% | +4.2% | -1.3% | -3.2% | +0.1% | — |
| Aug 1, 2024 | AMC | 0.57 | 0.38 | -33.3% | 23.31 | -13.8% | -11.9% | -8.7% | -0.2% | -4.8% | +2.4% | — |
| Apr 30, 2024 | AMC | 0.18 | 0.32 | +77.8% | 26.75 | -0.5% | -2.8% | +0.6% | +1.6% | +3.0% | +2.2% | — |
| Mar 27, 2024 | AMC | 0.29 | 0.31 | +6.9% | 28.88 | -13.4% | -9.1% | +9.4% | -3.9% | +4.0% | -5.0% | — |
| Oct 26, 2023 | AMC | 0.77 | 0.64 | -16.9% | 24.24 | -1.1% | -2.7% | +4.8% | -2.5% | -0.7% | +2.1% | — |
| Jul 27, 2023 | AMC | 1.09 | 1.10 | +0.9% | 37.95 | -1.4% | -3.6% | +1.1% | -0.3% | -0.6% | -0.2% | — |
| Apr 27, 2023 | AMC | 0.47 | 0.98 | +108.5% | 27.95 | -1.1% | +4.0% | +2.4% | +2.0% | -3.8% | -2.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28 | Truist | Maintains | Buy → Buy | — | $26.48 | $26.58 | +0.4% | -2.9% | +2.5% | +2.3% | +2.9% | -1.8% |
| Apr 9 | UBS | Maintains | Buy → Buy | — | $21.43 | $21.34 | -0.4% | +1.9% | +4.0% | +1.5% | -0.7% | +0.6% |
| Apr 9 | Truist | Maintains | Buy → Buy | — | $21.43 | $21.34 | -0.4% | +1.9% | +4.0% | +1.5% | -0.7% | +0.6% |
| Mar 5 | Mizuho | Maintains | Outperform → Outperform | — | $17.53 | $17.71 | +1.0% | -4.4% | -2.0% | +6.2% | +2.2% | +0.5% |
| Feb 25 | Goldman Sachs | Maintains | Neutral → Neutral | — | $18.41 | $18.59 | +1.0% | -2.1% | -3.9% | +5.3% | -1.4% | -6.8% |
| Feb 23 | UBS | Maintains | Buy → Buy | — | $17.04 | $16.81 | -1.3% | +5.8% | +2.1% | -2.1% | -3.9% | +5.3% |
| Feb 23 | BMO Capital | Maintains | Outperform → Outperform | — | $17.04 | $16.81 | -1.3% | +5.8% | +2.1% | -2.1% | -3.9% | +5.3% |
| Feb 23 | JP Morgan | Maintains | Neutral → Neutral | — | $17.04 | $16.81 | -1.3% | +5.8% | +2.1% | -2.1% | -3.9% | +5.3% |
| Feb 23 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $17.04 | $16.81 | -1.3% | +5.8% | +2.1% | -2.1% | -3.9% | +5.3% |
| Jan 21 | Truist | Maintains | Buy → Buy | — | $15.26 | $15.84 | +3.8% | +6.1% | -0.9% | -1.8% | +0.3% | -1.1% |
| Dec 3 | JP Morgan | Maintains | Neutral → Neutral | — | $12.77 | $12.71 | -0.5% | +1.5% | -3.2% | +1.3% | -3.9% | +1.6% |
| Nov 11 | UBS | Maintains | Buy → Buy | — | $12.75 | $12.75 | +0.0% | -0.8% | -0.3% | -2.7% | -3.1% | -5.4% |
| Nov 10 | RBC Capital | Maintains | Outperform → Outperform | — | $12.51 | $12.62 | +0.9% | +1.9% | -0.8% | -0.3% | -2.7% | -3.1% |
| Nov 10 | Truist | Maintains | Buy → Buy | — | $12.51 | $12.62 | +0.9% | +1.9% | -0.8% | -0.3% | -2.7% | -3.1% |
| Oct 16 | Mizuho | Maintains | Outperform → Outperform | — | $14.42 | $14.29 | -0.9% | -4.6% | -6.2% | +3.2% | +0.4% | +1.2% |
| Oct 6 | UBS | Maintains | Buy → Buy | — | $16.13 | $16.40 | +1.7% | -2.0% | -4.5% | -0.3% | -8.6% | -8.7% |
| Sep 23 | Mizuho | Maintains | Outperform → Outperform | — | $17.02 | $17.21 | +1.1% | -3.1% | -0.8% | -6.3% | +2.2% | -0.4% |
| Sep 16 | Truist | Maintains | Buy → Buy | — | $17.26 | $17.34 | +0.5% | -1.0% | +0.5% | +2.1% | -3.0% | +0.1% |
| Jul 15 | Mizuho | Maintains | Outperform → Outperform | — | $13.49 | $13.73 | +1.8% | -2.4% | +0.6% | +3.2% | -0.8% | +0.1% |
| Jul 3 | RBC Capital | Maintains | Outperform → Outperform | — | $12.73 | $13.02 | +2.3% | +1.6% | -3.9% | +9.7% | +1.0% | +2.0% |
| May 28 | Barclays | Maintains | Equal Weight → Equal Weight | — | $10.62 | $10.57 | -0.5% | -5.7% | +1.0% | +0.2% | -7.2% | +5.6% |
| May 14 | Goldman Sachs | Maintains | Neutral → Neutral | — | $11.78 | $11.63 | -1.3% | -3.1% | -3.3% | +1.2% | +0.1% | -0.1% |
| May 12 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $11.06 | $11.68 | +5.6% | +8.4% | -1.8% | -3.1% | -3.3% | +1.2% |
| May 8 | RBC Capital | Maintains | Outperform → Outperform | — | $10.90 | $11.18 | +2.6% | +3.1% | -1.6% | +8.4% | -1.8% | -3.1% |
| May 7 | UBS | Maintains | Buy → Buy | — | $12.10 | $10.32 | -14.7% | -9.9% | +3.1% | -1.6% | +8.4% | -1.8% |
| Apr 14 | Truist | Maintains | Buy → Buy | — | $11.28 | $11.62 | +3.0% | +2.1% | -3.6% | -0.8% | +3.1% | -0.4% |
| Apr 1 | Barclays | Maintains | Equal Weight → Equal Weight | — | $13.53 | $13.25 | -2.1% | -4.2% | +0.8% | -12.6% | -7.0% | -0.8% |
| Mar 27 | Mizuho | Upgrade | Neutral → Outperform | — | $13.83 | $14.11 | +2.0% | +3.3% | -4.0% | -1.4% | -4.2% | +0.8% |
| Feb 24 | Barclays | Maintains | Equal Weight → Equal Weight | — | $16.76 | $16.71 | -0.3% | -3.6% | -2.2% | +1.3% | -5.0% | -1.6% |
| Feb 19 | BMO Capital | Maintains | Outperform → Outperform | — | $17.48 | $16.72 | -4.3% | -1.8% | +1.9% | -4.1% | -3.6% | -2.2% |
| Jan 13 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $17.64 | $17.66 | +0.1% | +4.2% | +1.4% | +0.9% | +1.6% | +1.6% |
| Jan 7 | Mizuho | Maintains | Neutral → Neutral | — | $16.93 | $17.44 | +3.0% | +10.8% | -4.6% | -1.5% | +4.2% | +1.4% |
| Jan 7 | Goldman Sachs | Maintains | Neutral → Neutral | — | $16.93 | $17.44 | +3.0% | +10.8% | -4.6% | -1.5% | +4.2% | +1.4% |
| Dec 12 | RBC Capital | Maintains | Outperform → Outperform | — | $19.42 | $19.40 | -0.1% | -0.1% | -1.9% | -1.5% | -2.9% | -4.7% |
| Nov 6 | RBC Capital | Maintains | Outperform → Outperform | — | $19.88 | $20.58 | +3.5% | +4.2% | -1.3% | -3.2% | +0.1% | -2.6% |
| Nov 5 | Barclays | Maintains | Equal Weight → Equal Weight | — | $20.58 | $20.14 | -2.1% | -3.4% | +4.2% | -1.3% | -3.2% | +0.1% |
| Nov 5 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $20.58 | $20.14 | -2.1% | -3.4% | +4.2% | -1.3% | -3.2% | +0.1% |
| Oct 11 | RBC Capital | Maintains | Outperform → Outperform | — | $19.78 | $19.70 | -0.4% | +3.0% | -2.1% | -2.3% | +1.8% | -0.5% |
| Oct 7 | BMO Capital | Maintains | Outperform → Outperform | — | $19.57 | $19.85 | +1.4% | +2.6% | -2.6% | +0.6% | +0.6% | +3.0% |
| Sep 25 | Barclays | Maintains | Equal Weight → Equal Weight | — | $19.55 | $19.47 | -0.4% | -4.4% | +11.3% | -0.4% | -1.9% | -3.0% |
| Sep 3 | Goldman Sachs | Maintains | Neutral → Neutral | — | $19.44 | $18.92 | -2.7% | -4.2% | -0.5% | -0.2% | -5.6% | -2.1% |
| Aug 6 | UBS | Maintains | Buy → Buy | — | $18.75 | $18.75 | +0.0% | -0.2% | -4.8% | +2.4% | -0.8% | -1.4% |
| Aug 6 | BMO Capital | Maintains | Outperform → Outperform | — | $18.75 | $18.75 | +0.0% | -0.2% | -4.8% | +2.4% | -0.8% | -1.4% |
| Aug 6 | Barclays | Maintains | Equal Weight → Equal Weight | — | $18.75 | $18.75 | +0.0% | -0.2% | -4.8% | +2.4% | -0.8% | -1.4% |
| Aug 6 | JP Morgan | Maintains | Neutral → Neutral | — | $18.75 | $18.75 | +0.0% | -0.2% | -4.8% | +2.4% | -0.8% | -1.4% |
| Jul 9 | UBS | Upgrade | Neutral → Buy | — | $22.32 | $23.46 | +5.1% | +0.6% | +3.2% | +4.7% | +1.0% | +1.7% |
| Apr 9 | BMO Capital | Upgrade | Market Perform → Outperform | — | $27.05 | $28.00 | +3.5% | +4.1% | -2.3% | -0.8% | -3.0% | -1.7% |
| Apr 2 | UBS | Maintains | Neutral → Neutral | — | $28.74 | $28.19 | -1.9% | -3.9% | +4.0% | -5.0% | -1.0% | +0.1% |
| Apr 2 | Barclays | Maintains | Equal Weight → Equal Weight | — | $28.74 | $28.19 | -1.9% | -3.9% | +4.0% | -5.0% | -1.0% | +0.1% |
| Mar 5 | UBS | Downgrade | Buy → Neutral | — | $20.19 | $19.75 | -2.2% | +1.6% | +7.4% | +15.1% | +1.9% | +1.1% |
No insider trades available.
8-K · 5.02
!!! Very High
The Chemours Company -- 8-K 5.02: Executive Change
Apr 30
8-K · 1.01
! Medium
Unknown — 8-K 1.01: Financing / Debt Agreement
CC secured new financing through Deutsche Bank, providing capital flexibility that could fund operations or acquisitions, though investors should monitor debt terms and repayment obligations that affect future profitability.
Mar 12
8-K · 8.01
!! High
The Chemours Company -- 8-K 8.01: Material Event / Announcement
Chemours increased its senior unsecured debt offering to $700 million from $600 million, raising additional capital through 7.875% notes maturing in 2034.
Feb 26
8-K
The Chemours Company -- 8-K Filing
Chemours prioritized cash flow over earnings in its Advanced Performance Materials division, resulting in inventory charges and unfavorable product mix that slightly missed adjusted EBITDA guidance despite strong cash generation.
Feb 19
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Portfolio Management Llc | 10,325,341 | $227M | New | Mar 2026 |
| 2 | Vanguard Capital Management Llc | 6,773,917 | $149M | New | Mar 2026 |
| 3 | Wolf Hill Capital Management, Lp | 3,689,794 | $81M | New | Mar 2026 |
| 4 | Jpmorgan Chase & Co | 3,800,873 | $81M | Reduced | Mar 2026 |
| 5 | D.e. Shaw & Co | 2,851,010 | $63M | Added | Mar 2026 |
| 6 | Ubs Group Ag | 2,767,806 | $61M | Reduced | Mar 2026 |
| 7 | Morgan Stanley | 4,031,262 | $48M | Reduced | Dec 2025 |
| 8 | Bank Of New York Mellon Corp | 1,610,298 | $35M | Reduced | Mar 2026 |
| 9 | Northern Trust Corp | 1,565,825 | $34M | Added | Mar 2026 |
| 10 | Bank Of America Corp /de/ | 1,317,003 | $29M | Added | Mar 2026 |
| 11 | Marshall Wace, Llp | 1,253,283 | $28M | New | Mar 2026 |
| 12 | Bank Of Montreal /can/ | 1,002,979 | $22M | Reduced | Mar 2026 |
| 13 | Two Sigma Investments, Lp | 994,703 | $22M | Added | Mar 2026 |
| 14 | Woodline Partners Lp | 958,764 | $21M | New | Mar 2026 |
| 15 | Private Management Group Inc | 858,123 | $19M | Reduced | Mar 2026 |
| 16 | Fmr Llc | 848,923 | $19M | Reduced | Mar 2026 |
| 17 | Invesco Ltd. | 839,276 | $18M | Reduced | Mar 2026 |
| 18 | Point72 Asset Management | 609,271 | $13M | Added | Mar 2026 |
| 19 | Wells Fargo & Company/mn | 515,562 | $11M | New | Mar 2026 |
| 20 | Healthcare Of Ontario Pension Plan Trust Fund | 494,418 | $11M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$3.27B
Enterprise Value
$6.91B
P/E (TTM)
-8.60x
Forward P/E
15.11x
PEG Ratio
0.01x
P/B
13.04x
P/S
0.56x
P/FCF
64.26x
EV/EBITDA
20.80x
Shares Out
150.6M
Financials (TTM)
Revenue
$5.81B
Net Income
-$386.0M
EBITDA
$332.0M
Free Cash Flow
$51.0M
Op Cash Flow
$264.0M
EPS Basic
$-2.57
EPS Diluted
$-2.56
EPS Forward
$1.44
Gross Margin
15.5%
Op Margin
-0.1%
Net Margin
-6.7%
Balance Sheet
Total Assets
$7.38B
Total Liab.
$7.13B
Total Equity
$251.0M
Cash
$672.0M
LT Debt
$4.26B
Book Value/Sh
$1.67
Debt/Equity
18.34x
Current Ratio
1.78
Quick Ratio
0.85
Returns & Growth
ROE
-18.8%
ROA
-0.6%
ROIC
-0.1%
Rev Growth YoY
+0.4%
EPS Growth YoY
-543.1%
Price Returns
2W
-10.9%
1M
-17.8%
3M
+21.5%
6M
+73.3%
12M
+118.8%
Technicals
52W High
$28.67
52W Low
$10.14
50d MA
$23.30
200d MA
$17.39
RSI (14)
46.00
ATR (14)
$1.09
Beta
1.40
Avg Volume
2.7M
Dividends
Div Rate
$0.52
Div Yield
1.9%
Frequency
4
Ex-Div Date
Feb 27, 2026
Analyst Price Targets
Consensus
$22.14
High
$30.00
Low
$17.00
Median
$19.00
Data updated apr 25, 2026 12:12am
· Source: financialmodelingprep.com